Clinical Trial Update: Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on an adjuvant three-step chemotherapy regimen for BRCA1/2 wild-type ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Adjuvant Chemotherapy Three-step Regimen (ACTS-2)

Snippet

Sponsor: Fudan University | Conditions: Ovarian Cancer | Phase 3 | Status: RECRUITING